<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="brief-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id><journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id><journal-title-group><journal-title>BMC Research Notes</journal-title></journal-title-group><issn pub-type="epub">1756-0500</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7871548</article-id><article-id pub-id-type="publisher-id">5472</article-id><article-id pub-id-type="doi">10.1186/s13104-021-05472-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Note</subject></subj-group></article-categories><title-group><article-title>In vitro cytotoxicity of <italic>Aspilia pluriseta</italic> Schweinf. extract fractions</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1154-0777</contrib-id><name><surname>Njeru</surname><given-names>Sospeter N.</given-names></name><address><email>hicogn@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Muema</surname><given-names>Jackson M.</given-names></name><address><email>Jackson_mbithi@yahoo.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.448782.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1766 863X</institution-id><institution>Department of Biochemistry, School of Health Sciences, </institution><institution>Kisii University, </institution></institution-wrap>P.O. Box 408-40200, Kisii, Kenya </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411943.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9146 7108</institution-id><institution>Department of Biochemistry, </institution><institution>Jomo Kenyatta University of Agriculture and Technology (JKUAT), </institution></institution-wrap>P.O. Box 62000-00200, Nairobi, Kenya </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.425396.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 1019 0926</institution-id><institution>Present Address: Division of Immunology, </institution><institution>Paul-Ehrlich-Institute, Federal Institute for Vaccines and Biomedicines, </institution></institution-wrap>Paul-Ehrlich-Stra&#x000df;e 51-59, 63225 Langen, Hessen Germany </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>14</volume><elocation-id>57</elocation-id><history><date date-type="received"><day>17</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>1</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2021</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p id="Par1">We and others have shown that <italic>Aspilia pluriseta</italic> is associated with various biological activities. However, there is a lack of information on its cytotoxicity. This has created an information gap about the safety of <italic>A. pluriseta</italic> extracts. As an extension to our recent publication on the antimicrobial activity and the phytochemical characterization of <italic>A. pluriseta</italic> root extracts, here we report on cytotoxicity of tested solvent fractions. We evaluated the potential cytotoxicity of these root extract fractions on Vero cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.</p></sec><sec><title>Results</title><p id="Par2">We show that all solvent extract fractions (except methanolic solvent fractions) had cytotoxic concentration values that killed 50% of the Vero cells (CC<sub>50</sub>) greater than 20&#x000a0;&#x000b5;g/mL and selectivity index (SI) greater than 1.0. Taken together, we demonstrate that, <italic>A. pluriseta</italic> extract fractions&#x02019; earlier reported bioactivities are within the acceptable cytotoxicity and selective index limits. This finding scientifically validates the potential use of <italic>A. pluriseta</italic> in the discovery of safe therapeutics agents.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Vero cells</kwd><kwd>Medicinal/herbal plants</kwd><kwd>Traditional/folk medicine</kwd><kwd>MTT assay</kwd><kwd>Selectivity index</kwd><kwd>Phytochemicals</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004413</institution-id><institution>International Foundation for Science</institution></institution-wrap></funding-source><award-id>F/5372-1</award-id><principal-award-recipient><name><surname>Njeru</surname><given-names>Sospeter N.</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2021</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par11">Plant-derived products and compounds have been used to treat and manage a wide range of diseases and infections since ancient times. The utilization of plant-derived products and compounds is favoured because these products and compounds exhibit fewer side effects, have improved efficacy and have reduced chances of developing resistance [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>]. The bioactivity of plant extracts are a result of secondary metabolites, also called phytochemicals [<xref ref-type="bibr" rid="CR3">3</xref>]. These phytochemicals are produced for normal plant defences. However, they inadvertently work against microbial systems and thus are often tapped for therapeutic interventions.</p><p id="Par12">Here we extend the findings of our previous publications [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>] by looking at the safety of <italic>Aspilia pluriseta</italic> Schweinf. (<italic>Asteraceae</italic>) extract fractions in an in vitro system. <italic>A. pluriseta</italic> is a common herb in Kenya [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>], as well as in East, Central, and Southern Africa, [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. <italic>A. pluriseta</italic> is traditionally used to manage and treat wounds, cough, stomach illness, burn wounds, pimples, ears-, eye-, nose infections, kwashiorkor, fever, worms disorders, and diabetes mellitus with little or no scientific validation [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref>]. Recently we have reported <italic>A. pluriseta</italic> selective antitubercular activity [<xref ref-type="bibr" rid="CR5">5</xref>]. Other studies have reported <italic>A. pluriseta</italic> antiviral [<xref ref-type="bibr" rid="CR9">9</xref>], antihelmintic [<xref ref-type="bibr" rid="CR15">15</xref>], antimalarial, hypoglycaemic [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>], molluscicidal [<xref ref-type="bibr" rid="CR17">17</xref>] and complement modulating activities [<xref ref-type="bibr" rid="CR18">18</xref>]. However, the scientific evidence of its pharmacological activity is not fortified by data on its cytotoxicity. We therefore aimed to fill this scientific information-gap using an in vitro cytotoxicity system. We report that, the <italic>A. pluriseta</italic> extract fractions (except methanol solvent fraction) have CC<sub>50</sub>&#x02009;&#x0003e;&#x02009;20&#x000a0;&#x000b5;g/mL, and SI&#x02009;&#x0003e;&#x02009;1.0, which indicates that, <italic>A. pluriseta</italic> extract fractions are safe for use in drug discovery and that the reported bioactivity is not a result general toxicity.</p></sec><sec id="Sec2"><title>Main text</title><sec id="Sec3"><title>Methodology</title><sec id="Sec4"><title>Plant material collection</title><p id="Par13">Ethnopharmacological approach was used to identify the plant under study (<italic>A. pluriseta</italic>). This involved collecting information on <italic>A. pluriseta</italic> herbal use in the management and treatment of &#x0201c;strong coughs&#x0201d; and complicated respiratory infections from Mbeere community herbal practitioners. The gleaned information was further confirmed from documentation by Riley and Brokensha (1988) in <italic>The Mbeere in Kenya </italic>(ii)<italic>, Botanical identity and use</italic> [<xref ref-type="bibr" rid="CR19">19</xref>]. <italic>A. pluriseta</italic> root samples were collected in an open community field, and the plant is not among the endangered plant species. Therefore, no prior permission was sought before the plant samples were collected. We collected the plant samples within GPS co-ordinates 0&#x000b0;46&#x02032;27.0"S 37&#x000b0;40&#x02032;54.9"E; &#x02212;0.774156, 37.681908. Further authentication of plant sample identity was undertaken by Prof. S. T. Kariuki, a botanist at Egerton University, Kenya. A voucher specimen (number NSN2) was assigned and deposited at the same institution&#x02019;s herbalium.</p></sec></sec><sec id="Sec5"><title>Processing of plant samples</title><p id="Par14">The plant materials were processed, extracted and finally fractionated as described in Njeru and Muema [<xref ref-type="bibr" rid="CR5">5</xref>]. Briefly, root materials were cut into small pieces and allowed to air-dry in the dark at 23&#x02009;&#x000b1;&#x02009;2&#x000a0;&#x02103; until they attained a constant weight. They were thereafter ground into fine powder with an electric miller (Retsch SR 200, Haan, Germany). Fifty grams of ground material was macerated in 200&#x000a0;mL methanol (Sigma Aldrich, St. Louis, USA) for 48&#x000a0;h. The extract was filtered out using Whatmann 1 filter paper, and the process repeated once more. Both filtrates were pooled together, and excess methanol evaporated from the filtrate by a rotor evaporator (Laborota 4000 efficient, Heidolph, Germany). The resulting dry extract was stored at &#x02212;20&#x002da;C until use. To fractionate <italic>A. pluriseta</italic> root samples, we used organic solvents of increasing polarity (petro ether, dichloromethane, ethyl acetate and methanol respectively). Root powder (50&#x000a0;g) was macerated in 200&#x000a0;mL of petro ether solvent with intermittent shaking for 48&#x000a0;h. Thereafter, the extract was filtered out. Another 200&#x000a0;mL petro ether (PE) was added into plant material, and the process repeated after which the two filtrates were pooled together. The resulting marc was air-dried, after which it was further fractionated with solvents of increasing polarity (namely dichloromethane (DCM), ethyl acetate (EA), and finally methanol (MeOH) solvent in that order. The organic solvent fractions were concentrated with rotor evaporator as described before [<xref ref-type="bibr" rid="CR5">5</xref>]. For assays, the organic solvent fractions were reconstituted into appropriate stock solutions with 100% dimethyl sulfoxide (DMSO), but diluted appropriately with culture medium so that the final DMSO concentration in the test sample was one percent, and therefore 1% DMSO was used as the negative control. The antitubercular activity, general antimicrobial activity, as well as the analytical characterization of phytochemicals of crude extract and solvent extract fractions evaluated here have been reported in our previous publications [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p></sec><sec id="Sec6"><title>In vitro cytotoxicity test</title><p id="Par15">An MTT assay previously described by Njeru, Obonyo [<xref ref-type="bibr" rid="CR20">20</xref>] was followed to evaluate the toxicity of the <italic>A. pluriseta</italic> extract fractions on Vero cells (from African green monkey kidney cells (<italic>Cercopithecus aethiops</italic> epithelial cell line; ATCC CCL-81)). MTT assay is a colourimetric assay pegged on the ability of mitochondrial enzyme (succinate dehydrogenase) to reduce tetrazolium salt MTT to water-insoluble coloured substance (formazan) that is spectrophotometrically measurable [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. The amount of the formazan formed is directly proportional to the measure of cell viability. This is because only metabolically active cells can reduce MTT into formazan. The Vero cell line grown to 70&#x02013;80% confluency in a medium (containing 100&#x000a0;mL DMEM, 10&#x000a0;mL fetal bovine serum (FBS), 1&#x000a0;mL penicillin&#x02013;streptomycin, 1&#x000a0;mL amphotericin B, 1&#x000a0;mL L-glutamine and 0.1&#x000a0;mL gentamycin) was incubated in the presence of sample extract fractions at standard conditions (37&#x000a0;&#x02103; in 5% CO<sub>2</sub>) at 1.0&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/mL in a 96-well microtiter plate. The cells were exposed to decreasing concentrations of respective solvent extract fractions (250&#x02013;0.24&#x000a0;&#x003bc;g/mL for petroleum ether and dichloromethane fractions; 500&#x02013;0.49&#x000a0;&#x003bc;g/mL for ethyl acetate and methanolic fraction). Each sample concentration was tested in duplicates for 48&#x000a0;h. A post-exposure incubation of 4&#x000a0;h in 10 &#x000b5;L of 5&#x000a0;mg/mL MTT solution followed the addition of 100&#x000a0;&#x000b5;L acidified isopropanol (0.04&#x000a0;N HCl in isopropanol). The well plates were gently shaken for 5&#x000a0;min to dissolve the formazan in acidified isopropanol, and then optical density measured using ELISA Scanning Multiwell Spectrophotometer (LabSystems&#x02013;Multiskan EX) at 562&#x000a0;nm using 690&#x000a0;nm as the reference wavelengths. The last column of microtiter well plate containing medium without plant solvent extract fractions, but with 1% DMSO, was included as the negative control. The percentage cell viability (%) was calculated at each concentration using the formula provided below [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>].<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\text{Cell viablity }}\left( \% \right) = \frac{{{\text{OD of sample}}_{562} {\text{ - OD}}_{690} \, }}{{{\text{OD of control}}_{562} {\text{ - OD}}_{690} }}*100 $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mrow><mml:mtext>Cell viablity</mml:mtext><mml:mspace width="0.333333em"/></mml:mrow><mml:mfenced close=")" open="("><mml:mo>%</mml:mo></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mtext>OD of sample</mml:mtext></mml:mrow><mml:mn>562</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>- OD</mml:mtext></mml:mrow><mml:mn>690</mml:mn></mml:msub><mml:mspace width="0.166667em"/></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mtext>OD of control</mml:mtext></mml:mrow><mml:mn>562</mml:mn></mml:msub><mml:msub><mml:mrow><mml:mspace width="0.333333em"/><mml:mtext>- OD</mml:mtext></mml:mrow><mml:mn>690</mml:mn></mml:msub></mml:mrow></mml:mfrac><mml:mrow/><mml:mo>&#x02217;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math><graphic xlink:href="13104_2021_5472_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p><p id="Par16">Cytotoxic concentration values which represented the treatment concentration that kills 50% of the Vero cells (CC<sub>50</sub>), was determined by regression analysis. A particular plant solvent extract fraction was considered cytotoxic if it had CC<sub>50</sub> of less than 20&#x000a0;&#x003bc;g/mL and selectivity index (SI) of less than 1.0 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par17">The cytotoxicity test was performed against Vero cells (from monkey kidney fibroblast cells) to ascertain the safety of <italic>A. pluriseta</italic> solvent extract fractions. We chose the Vero cell line as an ideal in vitro model for the study because of its sensitivity to toxicity, ease to culture, and it was readily available in our test facility. Additionally, Vero cells are recommended as a model to detect basal cytotoxicity [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. In this study, we set a threshold of the cytotoxic concentration (CC<sub>50</sub>) below 20&#x000a0;&#x000b5;g/mL to be toxic, and above 20&#x000a0;&#x000b5;g/mL to be non-toxic as previously reported [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Our initial test for the cytotoxicity of the methanolic crude (cMeOH) extract revealed that the CC<sub>50</sub> was within the acceptable toxicity limit (CC<sub>50</sub> of 24.51) [<xref ref-type="bibr" rid="CR6">6</xref>]. Therefore, we hypothesized that fractionation could help us identify active fractions that would not only maintain a strong bioactivity [<xref ref-type="bibr" rid="CR5">5</xref>] but also be within the acceptable toxicity limits (CC<sub>50</sub>&#x02009;&#x0003e;&#x02009;20&#x000a0;&#x000b5;g/ml), and selectivity limits (SI&#x02009;&#x0003e;&#x02009;1.0). Solvent extract fractionation gave us one fraction (MeOH at CC<sub>50</sub> 14.36&#x000a0;&#x000b5;g/ml), which was cytotoxic. The PE fraction at CC<sub>50</sub> 78.6&#x000a0;&#x000b5;g/ml, DCM fraction, at CC<sub>50</sub> of 191.7&#x000a0;&#x000b5;g/ml, and EA fraction at CC<sub>50</sub>&#x02009;&#x0003e;&#x02009;500&#x000a0;&#x000b5;g/ml were all within the acceptable toxicity limit according to the set criteria (Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Cytotoxicity of <italic>A. pluriseta</italic> solvent crude and fraction extracts</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><sub>C</sub>MeOH</th><th align="left">PE</th><th align="left">DCM</th><th align="left">EA</th><th align="left">MeOH</th></tr></thead><tbody><tr><td align="left">CC<sub>50</sub> (&#x000b5;g/mL)</td><td char="." align="char">24.51</td><td char="." align="char">78.6</td><td char="." align="char">191.7</td><td align="left">&#x02009;&#x0003e;&#x02009;500</td><td char="." align="char">14.36</td></tr></tbody></table><table-wrap-foot><p><sub>C</sub>MeOH, Crude methanolic extract; PE, Petroleum ether solvent fraction; DCM, Dichloromethane solvent fraction; EA, Ethyl acetate solvent fraction; MeOH, Methanol solvent fraction; CC<sub>50</sub>, Concentration that kills 50% of the cells</p></table-wrap-foot></table-wrap></p><p id="Par18">To determine the selectivity index (SI) of the solvent extract fractions, we divided their CC<sub>50</sub> with their antitubercular MIC (all in &#x000b5;g/mL) (data published in [<xref ref-type="bibr" rid="CR5">5</xref>]) as previously done by others [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. The SI ranged from 1.1488 to 80 (Table <xref rid="Tab2" ref-type="table">2</xref>), which according to Afagnigni, Nyegue [<xref ref-type="bibr" rid="CR1">1</xref>] and Mongalo, McGaw [<xref ref-type="bibr" rid="CR24">24</xref>], suggested that the <italic>A. pluriseta</italic> extract fractions were not toxic, or, in the case of MeOH solvent extract fraction, that it exhibited cytotoxicity and antitubercular activity almost equally [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].<table-wrap id="Tab2"><label>Table 2</label><caption><p>Selectivity index of <italic>A. pluriseta</italic> solvent extract fractions</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">PE</th><th align="left">DCM</th><th align="left">EA</th><th align="left">MeOH</th></tr></thead><tbody><tr><td align="left">Selectivity index</td><td char="." align="char">3.144</td><td char="." align="char">7.668</td><td align="left">80</td><td char="." align="char">1.1488</td></tr></tbody></table><table-wrap-foot><p>PE, Petroleum ether solvent fraction; DCM, Dichloromethane solvent fraction; EA, Ethyl acetate solvent fraction; MeOH, Methanol solvent fraction</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Discussion</title><p id="Par19">Although plants&#x02019; contribution to new and novel leads for therapeutic drug development has been accepted for a long time now, it is currently a known fact that plant extracts are not always safe [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. The cytotoxicity of many herbal-derived products is a potential source of more deleterious side effects to subjects. It is, therefore, imperative to determine whether plant extracts and products showing potential drug activities are active within the acceptable toxicity and selectivity index limits [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Interestingly, we found that the crude extract and solvent extract fractions (except methanolic solvent extract fraction) demonstrated activity within the acceptable cytotoxicity limit (Table <xref rid="Tab1" ref-type="table">1</xref>). Furthermore, all the solvent fractions had selectivity index of&#x02009;&#x0003e;&#x02009;1.0, which further confirms that the solvent extract fractions are not toxic and hence the reported bioactivity in [<xref ref-type="bibr" rid="CR5">5</xref>] was not due to basal metabolic toxicity, or in the case of MeOH solvent extract fraction, the bioactivity and cytotoxicity are almost the same [<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec><sec id="Sec9"><title>Conclusion</title><p id="Par20">Our findings demonstrate that <italic>A. pluriseta</italic> root solvent extract fractions&#x02019; previously reported bioactivity is within acceptable cytotoxicity and selectivity index limit, and thus provide a potential source for safe drug candidate(s).</p></sec><sec id="Sec10"><title>Limitation</title><p id="Par21">It is important to note that the in vitro cytotoxicity results do not always equate to in vivo toxicity. This may be attributed to physiological, anatomical pharmacodynamic, and pharmacokinetic considerations in living animals and cell culture [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Therefore, there is a need for further in vivo toxicity assessment of the extract fractions. In this study, we evaluated the cytotoxicity of solvent extract fractions. However, it will be interesting in the future to isolate the active phytoconstituents (which we previously reported to be present in the tested extracts [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]) and test their individual biological and cytotoxicity effects.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>PE</term><def><p id="Par3">Petroleum ether</p></def></def-item><def-item><term>DCM</term><def><p id="Par4">Dichloromethane</p></def></def-item><def-item><term>EA</term><def><p id="Par5">Ethyl acetate</p></def></def-item><def-item><term>MeOH</term><def><p id="Par6">Methanol</p></def></def-item><def-item><term>cMeOH</term><def><p id="Par7">Crude methanolic extract</p></def></def-item><def-item><term>MTT</term><def><p id="Par8">3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></def></def-item><def-item><term>CC<sub>50</sub></term><def><p id="Par9">Cytotoxic concentration values that killed 50% of the Vero cells</p></def></def-item><def-item><term>SI</term><def><p id="Par10">Selective index</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would wish to acknowledge KEMRI- especially Dr. Bii C., among others, Kisii University (Prof. Anakalo S.) and Egerton University, (Prof. Matasyoh J.C., Prof. Ngari S.M., Dr. Obonyo A.M, and Mr. Nyambati S.O.) for the support they gave to the work.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>SNN conceived the idea, sought, and was awarded the funding and worked through the final draft. JMM partly performed the experimental studies, wrote the initial draft. Both authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was supported by the International Foundation for Science, Stockholm, Sweden, through IFS Grant No. F/5372-1 to Dr. Sospeter Ngoci, Njeru. The funding body did not participate in the design of the study and collection, analysis, and interpretation of data and in the writing of the manuscript.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article.</p></notes><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par22">Not applicable.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par23">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par24">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afagnigni</surname><given-names>AD</given-names></name><name><surname>Nyegue</surname><given-names>MA</given-names></name><name><surname>Djova</surname><given-names>SV</given-names></name><name><surname>Etoa</surname><given-names>F-X</given-names></name></person-group><article-title>LC-MS analysis, 15-lipoxygenase inhibition, cytotoxicity, and genotoxicity of dissotis multiflora (Sm) triana (melastomataceae) and <italic>Paullinia pinnata</italic> Linn (Sapindaceae)</article-title><source>J Trop Med</source><year>2020</year><volume>2020</volume><fpage>5169847</fpage><pub-id pub-id-type="doi">10.1155/2020/5169847</pub-id><pub-id pub-id-type="pmid">32148525</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mir</surname><given-names>MA</given-names></name><name><surname>Bashir</surname><given-names>N</given-names></name><name><surname>Alfaify</surname><given-names>A</given-names></name><name><surname>Oteef</surname><given-names>MDY</given-names></name></person-group><article-title>GC-MS analysis of <italic>Myrtus communis</italic> extract and its antibacterial activity against Gram-positive bacteria</article-title><source>BMC Complement Med Therapies</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>86</fpage><pub-id pub-id-type="doi">10.1186/s12906-020-2863-3</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuete</surname><given-names>V</given-names></name></person-group><article-title>Potential of Cameroonian plants and derived products against microbial infections: a review</article-title><source>Planta Med</source><year>2010</year><volume>76</volume><issue>14</issue><fpage>1479</fpage><lpage>1491</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250027</pub-id><pub-id pub-id-type="pmid">20533165</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batiha</surname><given-names>GE</given-names></name><name><surname>Beshbishy</surname><given-names>AM</given-names></name><name><surname>Alkazmi</surname><given-names>L</given-names></name><name><surname>Adeyemi</surname><given-names>OS</given-names></name><name><surname>Nadwa</surname><given-names>E</given-names></name><name><surname>Rashwan</surname><given-names>E</given-names></name><etal/></person-group><article-title>Gas chromatography-mass spectrometry analysis, phytochemical screening and antiprotozoal effects of the methanolic <italic>Viola tricolor</italic> and acetonic <italic>Laurus nobilis</italic> extracts</article-title><source>BMC Complement Med Therapies</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>87</fpage><pub-id pub-id-type="doi">10.1186/s12906-020-2848-2</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>SN</given-names></name><name><surname>Muema</surname><given-names>JM</given-names></name></person-group><article-title>Antimicrobial activity, phytochemical characterization and gas chromatography-mass spectrometry analysis of <italic>Aspilia pluriseta</italic> Schweinf. extracts</article-title><source>Heliyon.</source><year>2020</year><volume>6</volume><issue>10</issue><fpage>e05195</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e05195</pub-id><pub-id pub-id-type="pmid">33083626</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>SN</given-names></name><name><surname>Obonyo</surname><given-names>MA</given-names></name></person-group><article-title>Potency of extracts of selected plant species from Mbeere, Embu County-Kenya against <italic>Mycobacterium tuberculosis</italic></article-title><source>J Med Plants Res</source><year>2016</year><volume>10</volume><issue>12</issue><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.5897/JMPR2016.6044</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaouba</surname><given-names>S</given-names></name><name><surname>Valkonen</surname><given-names>A</given-names></name><name><surname>Coghi</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Guantai</surname><given-names>EM</given-names></name><name><surname>Derese</surname><given-names>S</given-names></name><etal/></person-group><article-title>Crystal structures and cytotoxicity of ent-kaurane-type diterpenoids from two <italic>Aspilia</italic> species</article-title><source>Molecules</source><year>2018</year><volume>23</volume><issue>12</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.3390/molecules23123199</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Gachathi FN. Kikuyu botanical dictionary: a guide to plant names, uses and cultural values. Trop Botany. 2007.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cos</surname><given-names>P</given-names></name><name><surname>Hermans</surname><given-names>N</given-names></name><name><surname>De Bruyne</surname><given-names>T</given-names></name><name><surname>Apers</surname><given-names>S</given-names></name><name><surname>Sindambiwe</surname><given-names>JB</given-names></name><name><surname>Witvrouw</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1)</article-title><source>Phytomedicine</source><year>2002</year><volume>9</volume><issue>1</issue><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1078/0944-7113-00083</pub-id><pub-id pub-id-type="pmid">11924766</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njoroge</surname><given-names>GN</given-names></name><name><surname>Bussmann</surname><given-names>RW</given-names></name></person-group><article-title>Traditional management of ear, nose and throat (ENT) diseases in Central Kenya</article-title><source>J Ethnobiol Ethnomed</source><year>2006</year><volume>2</volume><issue>1</issue><fpage>1</fpage><pub-id pub-id-type="doi">10.1186/1746-4269-2-1</pub-id><pub-id pub-id-type="pmid">16393342</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njoroge</surname><given-names>GN</given-names></name><name><surname>Bussmann</surname><given-names>RW</given-names></name></person-group><article-title>Ethnotherapeautic management of skin diseases among the Kikuyus of Central Kenya</article-title><source>J Ethnopharmacol</source><year>2007</year><volume>111</volume><issue>2</issue><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.11.025</pub-id><pub-id pub-id-type="pmid">17207950</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piero</surname><given-names>NM</given-names></name><name><surname>Joan</surname><given-names>MN</given-names></name><name><surname>Cromwell</surname><given-names>KM</given-names></name><name><surname>Joseph</surname><given-names>NJ</given-names></name><name><surname>Wilson</surname><given-names>NM</given-names></name><name><surname>Daniel</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hypoglycemic activity of some kenyan plants traditionally used to manage diabetes mellitus in Eastern Province</article-title><source>J Diabetes Metabol.</source><year>2011</year><pub-id pub-id-type="doi">10.4172/2155-6156.1000155</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuria</surname><given-names>JM</given-names></name><name><surname>Mbaria</surname><given-names>JM</given-names></name><name><surname>Gathumbi</surname><given-names>PK</given-names></name><name><surname>Kiama</surname><given-names>SG</given-names></name></person-group><article-title>Influence of <italic>Aspilia pluriseta</italic> Schweinf (Asteraceae) on the healing of dermal excision wounds (mouse model) and skin sensitization activity (Guinea pig model)</article-title><source>Afr J Pharmacol Ther</source><year>2015</year><volume>4</volume><issue>3</issue><fpage>112</fpage><lpage>117</lpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebisubi</surname><given-names>FM</given-names></name><name><surname>Odyek</surname><given-names>O</given-names></name><name><surname>Anokbonggo</surname><given-names>WW</given-names></name><name><surname>Ogwal-Okeng</surname><given-names>J</given-names></name><name><surname>Carcache-Blanco</surname><given-names>EJ</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><etal/></person-group><article-title>Antimalarial activity of <italic>Aspilia pruliseta</italic>, a medicinal plant from Uganda</article-title><source>Planta Med</source><year>2010</year><volume>76</volume><issue>16</issue><fpage>1870</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1055/s-0030-1250028</pub-id><pub-id pub-id-type="pmid">20539972</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njonge</surname><given-names>FK</given-names></name><name><surname>Mutugi</surname><given-names>M</given-names></name><name><surname>Kareru</surname><given-names>PG</given-names></name><name><surname>Githigia</surname><given-names>SM</given-names></name><name><surname>Waihenya</surname><given-names>R</given-names></name><name><surname>Nyakundi</surname><given-names>WO</given-names></name></person-group><article-title>Assessment of herbal anthelmintics used by the farmers in Kirinyaga County, Kenya, for the treatment of helminthiosis in cattle</article-title><source>Afr J Pharm Pharmacol</source><year>2013</year><volume>7</volume><issue>29</issue><fpage>2100</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.5897/AJPP2013.3511</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munster</surname><given-names>WB</given-names></name><name><surname>Dusseldorf</surname><given-names>RB</given-names></name><name><surname>Franz</surname><given-names>G</given-names></name><name><surname>Zurich</surname><given-names>OS</given-names></name><name><surname>Herz</surname><given-names>W</given-names></name><name><surname>Zurich</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Antimycobacterial plant terpenoids</article-title><source>Planta Med</source><year>2001</year><volume>67</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1055/s-2001-18365</pub-id><pub-id pub-id-type="pmid">11731906</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mwonga</surname><given-names>KB</given-names></name><name><surname>Mwaniki</surname><given-names>E</given-names></name><name><surname>Dorcas</surname><given-names>YS</given-names></name><name><surname>Piero</surname><given-names>NM</given-names></name></person-group><article-title>Molluscicidal effects of aqueous extracts of selected medicinal plants</article-title><source>Pharmaceutica Analytica Acta.</source><year>2015</year><pub-id pub-id-type="doi">10.4172/2153-2435.1000445</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cos</surname><given-names>P</given-names></name><name><surname>Hermans</surname><given-names>N</given-names></name><name><surname>Van Poel</surname><given-names>B</given-names></name><name><surname>De Bruyne</surname><given-names>T</given-names></name><name><surname>Apers</surname><given-names>S</given-names></name><name><surname>Sindambiwe</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Complement modulating activity of Rwandan medicinal plants</article-title><source>Phytomedicine</source><year>2002</year><volume>9</volume><issue>1</issue><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1078/0944-7113-00085</pub-id><pub-id pub-id-type="pmid">11924765</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>BW</given-names></name><name><surname>Brokensha</surname><given-names>D</given-names></name></person-group><source>The Mbeere in Kenya; Botanical identity and use Vol (ii)</source><year>1988</year><publisher-loc>USA</publisher-loc><publisher-name>University Press of America</publisher-name></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Njeru</surname><given-names>SN</given-names></name><name><surname>Obonyo</surname><given-names>MA</given-names></name><name><surname>Nyambati</surname><given-names>SO</given-names></name><name><surname>Ngari</surname><given-names>SM</given-names></name></person-group><article-title>Antimicrobial and cytotoxicity properties of the crude extracts and fractions of Premna resinosa (Hochst.) Schauer (Compositae): Kenyan traditional medicinal plant</article-title><source>BMC Complement Alternative Med</source><year>2015</year><volume>15</volume><fpage>295</fpage><pub-id pub-id-type="doi">10.1186/s12906-015-0811-4</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>Y</given-names></name><name><surname>Pathak</surname><given-names>R</given-names></name><name><surname>Kumari</surname><given-names>N</given-names></name><name><surname>Sah</surname><given-names>DK</given-names></name><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Kalra</surname><given-names>N</given-names></name><etal/></person-group><article-title>Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>1531</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-19930-w</pub-id><pub-id pub-id-type="pmid">29367754</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosmann</surname><given-names>T</given-names></name></person-group><article-title>Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays</article-title><source>J Immunol Methods</source><year>1983</year><volume>65</volume><issue>1</issue><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id><pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zulaikha</surname><given-names>N</given-names></name><name><surname>Zawawi</surname><given-names>M</given-names></name><name><surname>Shaari</surname><given-names>R</given-names></name><name><surname>Nordin</surname><given-names>ML</given-names></name><name><surname>Hamdan</surname><given-names>RH</given-names></name><name><surname>Peng</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Antibacterial and cytotoxic activity assessment of <italic>Channa striatus</italic> (Haruan) extract</article-title><source>Veterinary World</source><year>2020</year><volume>13</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2020.508-514</pub-id><pub-id pub-id-type="pmid">32367957</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mongalo</surname><given-names>NI</given-names></name><name><surname>McGaw</surname><given-names>LJ</given-names></name><name><surname>Finnie</surname><given-names>JF</given-names></name><name><surname>Staden</surname><given-names>JV</given-names></name></person-group><article-title>Pharmacological properties of extracts from six South African medicinal plants used to treat sexually transmitted infections ( STIs ) and related infections</article-title><source>South Afr J Botany</source><year>2017</year><volume>112</volume><fpage>290</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2017.05.031</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zirihi</surname><given-names>GN</given-names></name><name><surname>Mambu</surname><given-names>L</given-names></name><name><surname>Bodo</surname><given-names>B</given-names></name><name><surname>Grellier</surname><given-names>P</given-names></name></person-group><article-title>In vitro antiplasmodial activity and cytotoxicity of 33 West African plants used for treatment of malaria</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>98</volume><issue>3</issue><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2005.01.004</pub-id><pub-id pub-id-type="pmid">15814260</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omokhua</surname><given-names>AG</given-names></name><name><surname>Abdalla</surname><given-names>MA</given-names></name><name><surname>Staden</surname><given-names>JV</given-names></name><name><surname>McGaw</surname><given-names>LJ</given-names></name></person-group><article-title>A comprehensive study of the potential phytomedicinal use and toxicity of invasive Tithonia species in South Africa</article-title><source>BMC Complement Alternative Med</source><year>2018</year><volume>18</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s12906-018-2336-0</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>PF</given-names></name><name><surname>Peropadre</surname><given-names>A</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>JMP</given-names></name><name><surname>Herrero</surname><given-names>O</given-names></name><name><surname>Hazen</surname><given-names>MJ</given-names></name></person-group><article-title>Toxicology in vitro an integrated cellular model to evaluate cytotoxic effects in mammalian cell lines</article-title><source>Toxicol In Vitro</source><year>2009</year><volume>23</volume><issue>8</issue><fpage>1553</fpage><lpage>1558</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2009.06.017</pub-id><pub-id pub-id-type="pmid">19540333</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayarathna</surname><given-names>S</given-names></name><name><surname>Sasidharan</surname><given-names>S</given-names></name></person-group><article-title>Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines</article-title><source>Asian Pac J Trop Biomed</source><year>2012</year><volume>2</volume><issue>10</issue><fpage>826</fpage><lpage>829</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(12)60237-8</pub-id><pub-id pub-id-type="pmid">23569855</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makhafola</surname><given-names>TJ</given-names></name><name><surname>McGaw</surname><given-names>LJ</given-names></name><name><surname>Eloff</surname><given-names>JN</given-names></name></person-group><article-title>In vitro cytotoxicity and genotoxicity of five <italic>Ochna</italic> species (Ochnaceae) with excellent antibacterial activity</article-title><source>South Afr J Botany</source><year>2014</year><volume>91</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2013.11.010</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Stefanovi&#x00107; O, Radojevi&#x00107; I, Vasi&#x00107; S, &#x0010c;omi&#x00107; L. Antibacterial activity of naturally occurring compounds from selected plants. American Phytopathol Soc. 2005:1&#x02013;24.</mixed-citation></ref></ref-list></back></article>